Johnson & Johnson swings to loss as it books multibillion-dollar charge to settle talc claims

Johnson & Johnson’s stock rose 1.4% in premarket trade Tuesday, after the consumer health and pharmaceutical company beat consensus estimates for the first quarter, raised its full-year guidance and boosted its quarterly dividend by 5.3%. The company JNJ, swung to a loss of $68 million, or 3 cents…

#johnsonjohnsons #jnj #tylenol #motrin #darzalex #erelada #eps #merck #prometheus